Xylem Inc. (NYSE:XYL - Get Free Report) saw a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 3,390,000 shares, a growth of 47.4% from the November 15th total of 2,300,000 shares. Based on an average trading volume of 1,280,000 shares, the days-to-cover ratio is currently 2.6 days.
Wall Street Analyst Weigh In
Several research analysts recently commented on XYL shares. Wolfe Research reaffirmed a "peer perform" rating on shares of Xylem in a research note on Thursday. Citigroup raised shares of Xylem from a "neutral" rating to a "buy" rating and raised their target price for the stock from $135.00 to $148.00 in a research report on Monday, December 9th. TD Cowen lowered their price target on Xylem from $138.00 to $125.00 and set a "hold" rating for the company in a report on Wednesday, November 6th. Royal Bank of Canada reduced their price objective on Xylem from $163.00 to $162.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Finally, Robert W. Baird dropped their price target on Xylem from $175.00 to $154.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $152.20.
View Our Latest Stock Report on Xylem
Xylem Stock Down 0.4 %
XYL stock traded down $0.47 during trading on Friday, reaching $120.60. 1,353,557 shares of the company traded hands, compared to its average volume of 1,567,121. The company has a market capitalization of $29.30 billion, a price-to-earnings ratio of 35.26, a price-to-earnings-growth ratio of 2.22 and a beta of 1.05. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96. The business has a 50 day simple moving average of $127.72 and a 200 day simple moving average of $132.45. Xylem has a 12 month low of $109.38 and a 12 month high of $146.08.
Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, meeting analysts' consensus estimates of $1.11. The business had revenue of $2.10 billion for the quarter, compared to analysts' expectations of $2.17 billion. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The company's revenue was up .2% compared to the same quarter last year. During the same period last year, the business earned $0.99 EPS. On average, equities research analysts anticipate that Xylem will post 4.23 earnings per share for the current fiscal year.
Xylem Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 24th. Stockholders of record on Tuesday, November 26th will be given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date is Tuesday, November 26th. Xylem's payout ratio is presently 42.11%.
Institutional Trading of Xylem
A number of institutional investors have recently made changes to their positions in the business. Charles Schwab Investment Management Inc. grew its holdings in shares of Xylem by 0.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,345,768 shares of the industrial products company's stock valued at $181,719,000 after buying an additional 5,817 shares during the last quarter. Victory Capital Management Inc. grew its stake in Xylem by 9.3% during the 3rd quarter. Victory Capital Management Inc. now owns 1,627,279 shares of the industrial products company's stock valued at $219,731,000 after purchasing an additional 137,883 shares during the last quarter. Groupama Asset Managment increased its holdings in shares of Xylem by 89.6% in the third quarter. Groupama Asset Managment now owns 16,340 shares of the industrial products company's stock valued at $2,206,000 after purchasing an additional 7,723 shares during the period. BNP Paribas Financial Markets lifted its holdings in shares of Xylem by 16.5% during the third quarter. BNP Paribas Financial Markets now owns 547,435 shares of the industrial products company's stock worth $73,920,000 after purchasing an additional 77,639 shares during the period. Finally, Cerity Partners LLC boosted its position in Xylem by 22.9% in the third quarter. Cerity Partners LLC now owns 115,045 shares of the industrial products company's stock valued at $15,534,000 after buying an additional 21,464 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.
About Xylem
(
Get Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.